|
C60714 |
Apheresis product hematocrit percentage value |
The percentage value of hematocrit in apheresis product
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60661 |
Genetic therapy product manufacture date |
The date related to study treatment manufacture
|
Supplemental |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60669 |
Genetic therapy subcategory treatment type |
The type of study treatment subcategory.
|
Supplemental |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60698 |
Apheresis device program used text |
The free-text field related to apheresis device manufacturer and model.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60706 |
Adverse event relate apheresis indicator |
The indicator related to adverse event from apheresis.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60684 |
Red blood cell exchange performed most recent date |
The date related to last red blood cell exchange for treatment of sickle cell disease.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60692 |
Apheresis mobilization other agent type |
The other type of mobilization agent used in apheresis.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60676 |
Genetic therapy editing type |
The type related to type of gene editing.
|
Core |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60715 |
Apheresis product white blood cell count value |
The value related to white blood cells in apheresis product
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60662 |
Genetic therapy cell count |
The cell count related to biomanufacture in genetic therapy.
|
Core |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60670 |
Vector integrate type |
The type of vector integrating
|
Core |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60699 |
Anticoagulant agent administered text |
The free-text field related to anticoagulant agent administered.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60707 |
Anticoagulant agent additional administered indicator |
The indicator related to additional anticoagulant agent being administered
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60685 |
Hemoglobin S prior red blood exchange percentage value |
The percentage value of hemoglobin S prior to red blood exchange.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60693 |
Apheresis mobilization other agent dose value |
The dose related other agent for mobilization in apheresis.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60677 |
Genetic therapy editing other text |
The other specify related to type of gene editing.
|
Core |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60708 |
Anticoagulant agent additional administered type |
The type related to additional anticoagulant agent being administered.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60716 |
Apheresis product platelet count value |
The value related to platetet cells in apheresis product
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60663 |
Genetic therapy CD34 cell count |
The CD34 cell count related to biomanufacture in genetic therapy.
|
Core |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60671 |
Vector integrate other text |
The free-text field related to other vector integrating type.
|
Core |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60700 |
Apheresis average flow rate value |
The value related to average flow rate in apheresis
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60686 |
Hemoglobin S post red blood exchange percentage value |
The percentage value of hemoglobin S post red blood exchange.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60694 |
Apheresis mobilization other agent prior collection time value |
The value related to time prior to collection for administration of other agent for mobilization in apheresis.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60678 |
Nuclease delivery mode type |
The type related to mode of nuclease delivery
|
Core |
1.00 |
2021-05-10 12:12:04.0 |
Drug Product |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
|
C60709 |
Anticoagulant agent apheresis collection total value |
The total anticoagulant during the apheresis collection.
|
Exploratory |
1.00 |
2021-05-10 12:12:04.0 |
Apheresis |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
